A Phase II Clinical Study on the First-line Treatment of Advanced Liver Cancer With Chidamide Combined With Sintilimab and Bevacizumab
Latest Information Update: 13 May 2024
At a glance
- Drugs Bevacizumab (Primary) ; Sintilimab (Primary) ; Tucidinostat (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 May 2024 New trial record